Jason Novak is a Partner in Haynes and Boone’s Precision Medicine and Digital Health Practice Group, where he focuses on advising entities, both large and small, on the various legal issues that can arise with emerging technologies in the healthcare and life sciences industries. Tech and Biotech are traditionally disparate technologies that, when blended together to form many of our most exciting new technologies, bring forth a combination of unique and interrelated legal issues.

Jason has extensive experience in IP strategy and patent portfolio management, preparation and prosecution, oppositions, counseling, licensing and technology transactions, in and out-licensing, freedom-to-operate, various types of due diligence, IP training, risk recognition and management, and dispute resolution. He directs that experience to clients in various industries, particularly in the medical device, personalized/precision medicine (e.g., genomic sequencing platforms, computational genomics/bioinformatics, and molecular diagnostics), digital health, life sciences tooling, and food industries.

Prior to starting this practice, Jason was a IP Director for Thermo Fisher Scientific, where he managed worldwide IP needs in genetic sciences instrumentation and software (e.g., qPCR, dPCR, capillary electrophoresis). Jason managed large IP portfolios, a team of agents and attorneys, licensing programs, various diligence needs, various IP-related transactions, and foreign and domestics patent challenges.

Before moving into the legal industry, Jason was a research engineer for a leading food product company, where he led numerous product and process redesigns, reformulations and launches. This cross-functional role required interaction and experience with operations, finance, marketing and regulatory areas, contributing to Jason’s ability to deal with various corporate functions from both an R&D and legal perspective.

Professional and Community Activities

  • Member of the Bay Area IP Advisory Board for Chicago-Kent College of Law

Selected Publications and Speeches

  • “Initial Observations Regarding the USPTO’s Patents 4 Partnerships Pilot Program,” co-author, Intellectual Property & Technology Law Journal, Volume 33, No. 3, March 2021.
  • “Everything You Need to Know About Digital Health,” Cedars-Sinai Accelerator, November 2019.
  • “HITLAB World Cup Challenge,” May 2019.
  • “Life Sciences Bootcamp for In-House Counsel,” July 2019.
  • “IP Protection Strategies for Personalized/Precision Medicine,” BIOCOM, November 2018 (San Francisco).
  • “Intellectual Property 101”, Good Food Institute, September 2018.
  • “LES SVC: How to Run a Patent Prosecution Practice to Maximize Global Revenue from Licensing: A Perspective from Three Industries”, Licensing Executives Society, October 2017.

Show More
Expand All
Publications and Speaking Engagements
  • "The Business of Alt Protein: Intellectual Property for Alternative Protein Companies," speaker, Good Food Institute (GFI) webinar, June 16, 2021.
  • "Digital Health Innovations – What They Are, How to Protect Them, and Commercialization Strategies," speaker, Weill Digital Health Series webinar, March 12, 2021.
  • "Initial Observations Regarding the USPTO's Patents 4 Partnerships Pilot Program," co-author, IP & Technology Law Journal, Vol. 33 No. 3, March 2021. Read here.
  • "Qualifying for the USPTO's COVID-19 Prioritized Examination Pilot Program," co-author, IP & Technology Law Journal, Vol. 33 No. 2, February 2021. Read here.
  • "Navigating Legal Issues in Emerging Technologies in Healthcare & Life Sciences," contributor, UCSF Rosenman Institute Expert Consults, January 19, 2021.
  • "Digital Health 2021," contributor, International Comparative Legal Guides (ICLG), January 3, 2021. Read here.
  • "Telehealth and Other Advancements in Healthcare Technology Spurred by COVID-19," speaker, DahShu Online Seminar, November 13, 2020.
  • "IP Diligence Considerations," speaker, Idea-to-IPO webinar, September 17, 2020.
  • "How to Protect Your Intellectual Property," speaker, Idea-to-IPO webinar, June 30, 2020.
  • "Regulatory/Legal Challenges," speaker, 3DHEALS 2020, June 6, 2020.


B.S., Chemical Engineering, Illinois Institute of Technology, 2000, with honors

J.D., ChicagoKent College of Law, 2006




U.S. Patent and Trademark Office

Press Release
Haynes Boone Advises Biotech Startup Mekonos in Partnership With Investors
November 10, 2021

A Haynes and Boone, LLP team led by Partner Jason Novak advised biotech startup Mekonos, which raised more than $25 million in an oversubscribed Series A round. Headquartered in San Francisco, Mekonos is using scalable silicon technology for hyper-precise ex vivo delivery of molecules into cells. It has developed a chip technology platform that supports delivery of cell payloads at the single cel [...]